PODD

133.5032.72%
JH

Jessica Hopfield

Independent Director

Drs. Jessica Hopfield, Ph.D., served as Independent Director of Bruker Cellular Analysis, Inc. since December 15, 2021 until October 2, 2023. She was an Independent Director at Maravai LifeSciences Holdings, Inc. since November 19, 2020 until October 27, 2025. She had been a Director of Radius Health, Inc. since January 24, 2019 until December 31, 2020. Drs. Hopfield is an Independent Director of Editas Medicine Inc. since February 16, 2018 and serves as its Chairman since December 31, 2024 and served as its Lead Director since February 2021 until May 2024. She is a strategic advisor and Investor in start-up healthcare firms. Drs. Hopfield is a scientist and business leader with more than two decades of experience in the medical and healthcare fields. She held management positions at Merck Sharp & Dohme Corp. in clinical development, outcomes research and marketing. She served as a Partner and Associate of Global pharmaceutical Practice at McKinsey & Company from 1995 to 2009, where she led work in strategy, R&D management and marketing across pharmaceutical, biotech, medical device and consumer industries. In 2010, she founded J Hopfield Consulting to provide strategic guidance and executive coaching to start-up technology firms seeking to commercialize intellectual property. She has more than two decades of top-tier healthcare experience. She previously served as the Chairperson of Joslin Diabetes Center, Inc. until February 2018. Since 2010, Drs. Hopfield has been the Principal at J Hopfield Consulting providing guidance and executive coaching to start-up technology firms. Drs. Hopfield is an Independent Consultant, Strategic Advisor, Investor and Board Member to start-up technology firms. She served as Vice Chairman of the Joslin Diabetes Center from 2013 to October 2015. She has been a Director at rEVO Biologics, Inc. since November 2014. She had been Lead Independent Director of Insulet Corporation since August 2016 until January 2019 and has been its Independent Director since July 28, 2015. She has been a Trustee of Joslin Diabetes Center, Inc. since January 14, 2014 and served as its Chair since 2019. Drs. Hopfield holds a Ph.D. in Biological Sciences, Neuroscience/Biochemistry from The Rockefeller University, an MBA from Harvard Business School and a BS in Biology from Yale College.

Positions